The world’s leading plasma companies have formed the CoVIg-19 Plasma Alliance, aimed at treating the new coronavirus. CSL Behring, CSL Plasma’s parent company, is a founding member of the Alliance. The first step is collecting plasma from healthy individuals at collection centers across the U.S. who have recovered from COVID-19. Known as convalescent plasma, the plasma of recovered COVID-19 patients contains critical antibodies that may be used to make an experimental treatment. This is where you can help!
If your doctor has confirmed that you have fully recovered from COVID-19 and are no longer contagious, we invite you to learn more about the process of donating your plasma towards this important effort. CSL Plasma is working with Leapcure to recruit potential plasma donors.